ForMyGluco
BlogGlossary← Home

Which organs it reaches

Which organs does sugar touch?

· 3 min

Leafless tree branches silhouetted against a pink-lilac twilight sky; the fine branches fill the square like a capillary network.

High glucose doesn’t touch organs directly; first it wears the inner surface of the vessels feeding them. Damage builds on two scales: in fine capillaries the eyes, kidneys and nerves; in large arteries the heart, brain and legs. The two scales differ in mechanism, in speed and in their signs.

Blood reaches every organ through vessels, and a thin cell layer, the endothelium, lines them inside. Glucose running high for long wears this layer first: inflammatory processes quicken, oxidative load rises, the vessel’s power to relax drops. In most organs damage starts here. Nerves stand apart: affected both by the feeding capillary and directly by the metabolic load. Which organ gets in line depends on where in the body that vessel feeds.

The vessel network isn’t one size; wear builds on two separate scales, by two separate mechanisms. In capillaries the basement membrane thickens, capillaries clog, vanish one by one; blood to the tissue they feed drops. This scale covers the eye’s retina, the kidney’s filtering units, the nerves’ feeding vessels. In large arteries the picture differs: fatty plaque builds in the wall, the vessel narrows, clotting tendency rises. Heart, brain and leg arteries sit on this side. The heart-and-vessels piece covers how plaque is built, and why the real break comes at the moment of tearing.

ScaleWhat it touchesWhat happens in the vessel
Fine capillariesEyes, kidneys, nervesBasement membrane thickens, capillaries clog, tissue left without blood
Large arteriesHeart, brain, legsPlaque builds in the wall, vessel narrows, clotting tendency rises

Timing differs too. The capillary side is the one tied most tightly to glucose; the link between average sugar and risk here is the strongest measured. On the large-vessel side glucose isn’t the only factor; blood pressure and blood fats weigh at least as much. In type 2 diabetes large-vessel wear has often begun before the name is given; even at borderline sugar, heart and vessel risk has already risen. One gathers quietly, the other announces itself with a single event.

Silence is this map’s hardest part. Capillary damage starting out neither hurts nor spoils vision; the person feels fine while the vessels have started changing. So the early stage is caught by looking, not feeling: the eye’s back examined, urine checked for albumin, the foot tested for sensation. On the large-vessel side the first trace often shows in a moment of exertion. Chest tightness climbing stairs, calf pain that starts on walking and passes on stopping, one foot staying markedly colder than the other.

Are all organs affected at once?
No, the two scales keep separate clocks. In one person eye involvement can be marked while the kidney’s filtering power holds. In the same person the large-vessel side can advance soundlessly.
How long does damage take to build up?
There is no single calendar. Blood pressure, blood fats and smoking weigh as much as time does. Because type 2 diabetes stays quiet for long, in some people eye or kidney involvement has already begun at diagnosis.
Is the brain on this map too?
Yes, on the large-vessel side. The same plaque process runs in the brain’s feeding arteries; raised stroke risk comes from there. A stroke announces itself suddenly, not gradually: one side of the face dropping, weakness appearing in one arm, speech breaking down, sight going in one eye. This picture is measured in minutes and needs urgent medical assessment.

The map ends here; the road itself doesn’t. Every organ has its own signs, own way of being looked at, own time scale; separate pieces open each in turn. The common point: eye, kidney, nerve, heart and leg look like far-apart organs, yet they are different addresses in the same vessel story.

Sources

  1. Yang DR, Zhang MY, Zhang CL, Wang Y. Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications. Front Endocrinol (Lausanne). 2024;15:1359255. doi:10.3389/fendo.2024.1359255
  2. Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-412. doi:10.1136/bmj.321.7258.405
  3. Cai X, Zhang Y, Li M, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370:m2297. doi:10.1136/bmj.m2297
  4. American Diabetes Association Professional Practice Committee. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Supplement_1):S216–S245. doi:10.2337/dc26-S010. PMID: 41358899.
  5. World Health Organization. Diabetes (fact sheet). Geneva: WHO; 14 November 2024.

This piece is for information only; it is not a diagnosis, treatment or dosing recommendation. Always make decisions about your treatment together with your doctor.

Start keeping your own record

ForMyGluco keeps your readings, medications and appointments in one place, and prepares a doctor-ready PDF in a single tap.

View on the App Store →

All of the blog